Health Outcomes Research in Medicine
Volume 1, Issue 1 , Pages e51-e59 , July 2010

Preferences of Patients and Oncologists for Advanced Ovarian Cancer Treatment-Related Health States

  • Lisa M. Hess, PhD

      Affiliations

    • Arizona Cancer Center, University of Arizona, Tucson, Arizona
    • Departments of Public Health and Obstetrics and Gynecology, Indiana University School of Medicine, Indianapolis, Indiana
    • Corresponding Author InformationCorresponding Author: Lisa M. Hess, PhD, Department of Public Health, Indiana University School of Medicine, 714 North Senate Avenue EF250; Indianapolis, IN 46202.
    • ,
  • Daniel C. Malone, PhD

      Affiliations

    • College of Pharmacy, University of Arizona, Tucson, Arizona
    • ,
  • Pamela G. Reed, PhD

      Affiliations

    • College of Nursing, University of Arizona, Tucson, Arizona
    • ,
  • Grant Skrepnek, PhD

      Affiliations

    • College of Pharmacy, University of Arizona, Tucson, Arizona
    • ,
  • Karen Weihs, MD

      Affiliations

    • Arizona Cancer Center, University of Arizona, Tucson, Arizona
    • College of Medicine, Department of Psychiatry, University of Arizona, Tucson, Arizona

References 

  1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59(4):225–249
  2. Markman M. Pharmaceutical management of ovarian cancer: current status. Drugs. 2008;68(6):771–789
  3. Meyer T, Rustin GJ. Role of tumour markers in monitoring epithelial ovarian cancer. Br J Cancer. 2000;82(9):1535–1538
  4. Vergote I, Rustin GJ, Eisenhauer EA, et al. Re: new guidelines to evaluate the response to treatment in solid tumors [ovarian cancer]. Gynecologic Cancer Intergroup. J Natl Cancer Inst. 2000;92(18):1534–1535
  5. Llewellyn-Thomas HA. Patients’ health-care decision making: a framework for descriptive and experimental investigations. Med Decis Making. 1995;15(2):101–106
  6. Kassirer JP. Incorporating patients’ preferences into medical decisions. N Engl J Med. 1994;330(26):1895–1896
  7. Wakker PP, Deneffe D. Eliciting von-Neumann-Morgenstern utilities when probabilities are distorted or unknown. Manage Sci. 1996;41:1131–1150
  8. von Neumann J, Morgenstern O. Theory of Games and Economic Behavior. Princeton, NJ: Princeton University Press; 1944;
  9. Drummond MF, O’Brien G, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes. Oxford, UK: Oxford Medical Publications; 1997;
  10. Kostopoulou O. The transient nature of utilities and health preferences. Med Decis Making. 2006;26(4):304–306
  11. Loewenstein G. Out of control: visceral influences on behavior. Organ Behav Hum Decis Process. 1996;65(3):272–292
  12. Wright WF, Bower GH. Mood effects on subjective probability assessment. Organ Behav Hum Decis Process. 1992;52:276–291
  13. Kahneman D, Tversky A. Prospect theory: an analysis of decision under risk. Econometrica. 1979;4:263–291
  14. Hess LM, Malone DC, Skrepnek GH, Reed PG, Armstrong E, Coons SJ. Oncologist preferences for health states associated with the treatment of advanced ovarian cancer. Applied Health Econ Health Pol. 2010;8(4):217–223
  15. Dranitsaris G, Elia-Pacitti J, Cottrell W. Measuring treatment preferences and willingness to pay for docetaxel in advanced ovarian cancer. Pharmacoeconomics. 2004;22(6):375–387
  16. Sun CC, Bodurka DC, Weaver CB, et al. Rankings and symptom assessments of side effects from chemotherapy: insights from experienced patients with ovarian cancer. Support Care Cancer. 2005;13(4):219–227
  17. Verheijen RH, von Mensdorff-Pouilly S, van Kamp GJ, Kenemans P. CA 125: fundamental and clinical aspects. Semin Cancer Biol. 1999;9(2):117–124
  18. Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med. 2001;33(5):337–343
  19. Torrance GW, Feeny D, Furlong W. Visual analog scales: do they have a role in the measurement of preferences for health states?. Med Decis Making. 2001;21(4):329–334
  20. Froberg DG, Kane RL. Methodology for measuring health-state preferences—II: scaling methods. J Clin Epidemiol. 1989;42(5):459–471
  21. Lenert L, Kaplan RM. Validity and interpretation of preference-based measures of health-related quality of life. Med Care. 2000;38(9 Suppl):II138–II150
  22. Bell RB, Holleran S, Ramakrishnan R. Sample size determination. ILAR J. 2002;43(4):207–213
  23. Stein K, Sugar C, Velikova G, Stark D. Putting the ‘Q’ in quality adjusted life years (QALYs) for advanced ovarian cancer—an approach using data clustering methods and the internet. Eur J Cancer. 2007;43(1):104–113
  24. Calhoun EA, Bennett CL, Peeples PA, et al. Perceptions of cisplatin-related toxicity among ovarian cancer patients and gynecologic oncologists. Gynecol Oncol. 1998;71(3):369–375
  25. Stewart DE, Wong F, Cheung AM, et al. Information needs and decisional preferences among women with ovarian cancer. Gynecol Oncol. 2000;77(3):357–361
  26. Sun CC, Bodurka DC, Donato ML, et al. Patient preferences regarding side effects of chemotherapy for ovarian cancer: do they change over time?. Gynecol Oncol. 2002;87(1):118–128
  27. Ziebland S, Evans J, McPherson A. The choice is yours? How women with ovarian cancer make sense of treatment choices. Patient Educ Couns. 2006;62(3):361–367
  28. Hess LM, Malone DC, Skrepnek G, Coons SJ, Weihs K. A pilot study of ovarian cancer patient preferences: empirical support for non-linear decision making processes. International Psychooncology Society Annual Meeting, London, UK, September 16-20, 2007.
  29. Christensen-Szalanski JJ. Discount functions and the measurement of patients’ values. Women’s decisions during childbirth. Med Decis Making. 1984;4(1):47–58
  30. Jansen SJ, Kievit J, Nooij MA, Stiggelbout AM. Stability of patients’ preferences for chemotherapy: the impact of experience. Med Decis Making. 2001;21(4):295–306

 This study was supported by the Better than Ever Research Fund at the Arizona Cancer Center Division of Women’s Cancers, which had no role in the design, analysis, writing or interpretation of this study.

 None of the authors have any conflicts of interest to disclose.

PII: S1877-1319(10)00005-4

doi: 10.1016/j.ehrm.2010.02.001

Health Outcomes Research in Medicine
Volume 1, Issue 1 , Pages e51-e59 , July 2010

Article Tools

* Image Usage & Resolution